Clinical Trials Logo

Clinical Trial Summary

To compare the prognosis of patients with hypertensive intracerebral hemorrhage treated by two different surgical methods, and to clarify the therapeutic effect of minimally invasive surgery, so as to find a better surgical method that can reduce surgical trauma and mortality and improve the prognosis of patients


Clinical Trial Description

In this study, a cohort observation method was adopted to observe a total of 52 patients who underwent two surgical procedures, namely, removal of hematoma in basal ganglo-region by keyhole neuroendoscopy under frontal ultrasound guidance and removal of hematoma by craniotomy microsurgery. They were divided into the endoscopic surgery group and the microsurgery group. In the endoscopic surgery group, 26 patients underwent removal of hematoma in basal ganglo-region by keyhole neuroendoscopy under frontal ultrasound guidance.In the microsurgery group, 26 cases were treated with craniotomy microsurgery for hematoma removal. The clearance rate of surgical hematoma, surgical safety, GCS score, GOS score, nerve fiber injury and postoperative complications were observed in the two groups 1 week, 1 month and 3 months after surgery.To observe and analyze whether endoscopic surgery group has advantages in improving hematoma clearance rate and efficacy ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04958525
Study type Observational
Source Peking University Third Hospital
Contact Liu Bin
Phone 13671027688
Email liubin301@163.com
Status Recruiting
Phase
Start date February 1, 2021
Completion date July 1, 2023

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04172376 - Stereotactic Operation Integrating With Thrombolysis in Basal Ganglion Hemorrhage Evacuation II N/A
Completed NCT04839770 - MIECH: The Minimally Invasive Endoscopic Surgery With the Axonpen System for Spontaneous Intracerebral Hemorrhage N/A